Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 69

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 69
---
374 thousand, or 216.2%,
compared to Predecessor’s $173 thousand for the same period. The general and administrative expenses comprise mainly from salaries
and related expenses, share based payment expenses, professional services and other expenses. The increase was primarily attributable
to higher share-based payment expense, Successor’s salaries and related expenses and Successor’s professional services for
such period compared to not significant or no such expenses in the Predecessor for the same period.

Operating Loss

As a result of the foregoing, Successor’s
operating loss totaled $938 thousand for the three months period ended June 30, 2025, representing an increase of $189 thousand, or 25.2%,
compared to Predecessor’s $749 thousand loss for the same period.

Financing expense, Net

Successor recognized financing expense, net
of $34 thousand for the three months period ended June 30, 2025, representing an increase of $32 thousand, or 1,600.0%, compared to Predecessor’s
finance expense, net of $2 thousand for the same period. The increase in finance expense, net was primarily attributable to Successor’s
higher exchange rate differences between the U.S. dollar and the New Israeli Shekel.

Net and Comprehensive Loss

As a result of the foregoing, Successor’s
loss totaled $972 thousand for the three months period ended June 30, 2025, representing an increase of $221 thousand, or 29.4%, compared
to Predecessor’s $751 thousand for the same period.

<div align='center'>40</div>

Successor for the period from July 24, 2024 through December 31, 2024, the Predecessor period from January 1, 2024 through July 23, 2024, and for the year ended December 31, 2023

The following tables present selected financial
data for the Successor period from July 24, 2024 through December 31, 2024, the Predecessor period from January 1, 2024 through
July 23, 2024, and for the year ended December 31, 2023.

|                                     |     | Successor    
 through      
 December 31, 
 2024         |    For the 
     period 
 commencing 
    July 24 |   |     | Predecessor 
 through     
 July 23,    
 202